JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Endocrinology (2000) 166, 103-109       DOI: 10.1677/joe.0.1660103
© 2000 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (46)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halvorsen, T.
Right arrow Articles by Levine, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halvorsen, T.
Right arrow Articles by Levine, F
Journal of Endocrinology, Vol 166, Issue 1, 103-109
Copyright © 2000 by Society for Endocrinology

Articles

Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro

TL Halvorsen, GM Beattie, AD Lopez, A Hayek, and F Levine


Widespread application of beta-cell replacement strategies for diabetes is dependent upon the availability of an unlimited supply of cells exhibiting appropriate glucose-responsive insulin secretion. Therefore, a great deal of effort has been focused on understanding the factors that control beta-cell growth. Previously, we found that human beta-cell-enriched islet cultures can be stimulated to proliferate, but expansion was limited by growth arrest after 10-15 cell divisions. Here, we have investigated the mechanism behind the growth arrest. Our studies, including analyses of the expression of senescence-associated beta-galactosidase, p16(INK4a) levels, and telomere lengths, indicate that cellular senescence is responsible for limiting the number of cell divisions that human beta-cells can undergo. The senescent phenotype was not prevented by retroviral transduction of the hTERT gene, although telomerase activity was induced. These results have implications for the use of primary human islet cells in cell transplantation therapies for diabetes.


This article has been cited by other articles:


Home page
 DiabetesHome page
Y. Bar, H. A. Russ, S. Knoller, L. Ouziel-Yahalom, and S. Efrat
HES-1 Is Involved in Adaptation of Adult Human {beta}-Cells to Proliferation In Vitro
Diabetes, September 1, 2008; 57(9): 2413 - 2420.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. A. Russ, Y. Bar, P. Ravassard, and S. Efrat
In Vitro Proliferation of Cells Derived From Adult Human {beta}-Cells Revealed By Cell-Lineage Tracing
Diabetes, June 1, 2008; 57(6): 1575 - 1583.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Testa and A. Ceriello
Pathogenetic Loop Between Diabetes and Cell Senescence
Diabetes Care, November 1, 2007; 30(11): 2974 - 2975.
[Full Text] [PDF]

Home page
 DiabetesHome page
N. Weinberg, L. Ouziel-Yahalom, S. Knoller, S. Efrat, and Y. Dor
Lineage Tracing Evidence for In Vitro Dedifferentiation but Rare Proliferation of Mouse Pancreatic {beta}-Cells
Diabetes, May 1, 2007; 56(5): 1299 - 1304.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
I. Cozar-Castellano, N. Fiaschi-Taesch, T. A. Bigatel, K. K. Takane, A. Garcia-Ocana, R. Vasavada, and A. F. Stewart
Molecular Control of Cell Cycle Progression in the Pancreatic {beta}-Cell
Endocr. Rev., June 1, 2006; 27(4): 356 - 370.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
D. Kipling, T. Davis, E. L. Ostler, and R. G. A. Faragher
What Can Progeroid Syndromes Tell Us About Human Aging?
Science, September 3, 2004; 305(5689): 1426 - 1431.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
F. Levine and M. Mercola
No Pancreatic Endocrine Stem Cells?
N. Engl. J. Med., September 2, 2004; 351(10): 1024 - 1026.
[Full Text] [PDF]

Home page
 DiabetesHome page
A. Lechner, Y.-G. Yang, R. A. Blacken, L. Wang, A. L. Nolan, and J. F. Habener
No Evidence for Significant Transdifferentiation of Bone Marrow Into Pancreatic {beta}-Cells In Vivo
Diabetes, March 1, 2004; 53(3): 616 - 623.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. J. Evans, F. S. Wyllie, D. Wynford-Thomas, D. Kipling, and C. J. Jones
A P53-dependent, Telomere-independent Proliferative Life Span Barrier in Human Astrocytes Consistent with the Molecular Genetics of Glioma Development
Cancer Res., August 15, 2003; 63(16): 4854 - 4861.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Lechner and J. F. Habener
Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus
Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E259 - E266.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. M. Beattie, A. M.P. Montgomery, A. D. Lopez, E. Hao, B. Perez, M. L. Just, J. R.T. Lakey, M. E. Hart, and A. Hayek
A Novel Approach to Increase Human Islet Cell Mass While Preserving {beta}-Cell Function
Diabetes, December 1, 2002; 51(12): 3435 - 3439.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Assady, G. Maor, M. Amit, J. Itskovitz-Eldor, K. L. Skorecki, and M. Tzukerman
Insulin Production by Human Embryonic Stem Cells
Diabetes, August 1, 2001; 50(8): 1691 - 1697.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
D. Dufayet de la Tour, T. Halvorsen, C. Demeterco, B. Tyrberg, P. Itkin-Ansari, M. Loy, S.-J. Yoo, E. Hao, S. Bossie, and F. Levine
{beta}-Cell Differentiation from a Human Pancreatic Cell Line in Vitro and in Vivo
Mol. Endocrinol., March 1, 2001; 15(3): 476 - 483.
[Abstract] [Full Text]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society for Endocrinology.